EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern

Callum M Ives, Linh Nguyen, Carl A Fogarty, Aoife M Harbison, Yves Durocher, John Klassen iD, Elisa Fadda iD

eLife · 2024

DOI: 10.7554/elife.95708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Callum M Ives und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Maynooth University, Maynooth, Ireland. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Molecular Dynamics Simulation, Protein Binding. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, Irish Research Council, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycosylation of the SARS-CoV-2 spike (S) protein represents a key target for viral evolution because it affects both viral evasion and fitness. Successful variations in the glycan shield are difficult to achieve though, as protein glycosylation is also critical to folding and structural stability. Within this framework, the identification of glycosylation sites that are structurally dispensable can provide insight into the evolutionary mechanisms of the shield and inform immune surveillance. In this work, we show through over 45 μs of cumulative sampling from conventional and enhanced molecular dynamics (MD) simulations, how the structure of the immunodominant S receptor binding domain (RBD) is regulated by N -glycosylation at N343 and how this glycan’s structural role changes from WHu-1, alpha (B.1.1.7), and beta (B.1.351), to the delta (B.1.617.2), and omicron (BA.1 and BA.2.86) variants. More specifically, we find that the amphipathic nature of the N -glycan is instrumental to preserve the structural integrity of the RBD hydrophobic core and that loss of glycosylation at N343 triggers a specific and consistent conformational change. We show how this change allosterically regulates the conformation of the receptor binding motif (RBM) in the WHu-1, alpha, and beta RBDs, but not in the delta and omicron variants, due to mutations that reinforce the RBD architecture. In support of these findings, we show that the binding of the RBD to monosialylated ganglioside co-receptors is highly dependent on N343 glycosylation in the WHu-1, but not in the delta RBD, and that affinity changes significantly across VoCs. Ultimately, the molecular and functional insight we provide in this work reinforces our understanding of the role of glycosylation in protein structure and function and it also allows us to identify the structural constraints within which the glycosylation site at N343 can become a hotspot for mutations in the SARS-CoV-2 S glycan shield.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Molecular Dynamics SimulationProtein BindingGlycosylationHumansCOVID-19PolysaccharidesProtein DomainsBinding SitesProtein ConformationMutation

Stichwörter der Autor:innen

COVID-19RBDSARS-CoV-2glycosylationhumanmolecular biophysicsreceptor binding domainspikestructural biologyvariants

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Polysaccharides

Autor:innen und Institutionen

  • Department of Chemistry, Maynooth University, Maynooth, Ireland.
  • Department of Chemistry, University of Alberta, Edmonton, Canada.
  • Human Health Therapeutics Research Centre, Life Sciences Division, National Research Council Canada, Québec, Canada.
  • Département de Biochimie et Médecine Moléculaire, Université de Montréal, Québec, Canada.
  • School of Biological Sciences, University of Southampton, Southampton, United Kingdom.

ORCID-Profile: John Klassen, Elisa Fadda

Förderung

  • Science Foundation Ireland
  • Irish Research Council
  • Natural Sciences and Engineering Research Council of Canada
  • Canada Foundation for Innovation
  • Alberta Innovation and Advanced Education Research Capacity Program

Zitieren

APA

Ives, C. M., Nguyen, L., Fogarty, C. A., Harbison, A. M., Durocher, Y., Klassen, J., & Fadda, E. (2024). Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern. eLife. https://doi.org/10.7554/elife.95708

Vancouver

Ives CM, Nguyen L, Fogarty CA, Harbison AM, Durocher Y, Klassen J, et al. Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern. eLife. 2024. doi:10.7554/elife.95708

BibTeX
@article{Ives2024,
  author = {Ives, Callum M and Nguyen, Linh and Fogarty, Carl A and Harbison, Aoife M and Durocher, Yves and Klassen, John and Fadda, Elisa},
  title = {Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.95708}
}
Kostenlos starten →